The New England journal of medicine
-
Randomized Controlled Trial Multicenter Study
A multicenter, randomized trial of prophylactic fluconazole in preterm neonates.
Invasive candida infections are a major cause of morbidity and mortality in preterm infants. We performed a multicenter, randomized, double-blind, placebo-controlled trial of fluconazole for the prevention of fungal colonization and infection in very-low-birth-weight neonates. ⋯ Prophylactic fluconazole reduces the incidence of colonization and invasive candida infection in neonates weighing less than 1500 g at birth. The benefit of treating candida colonization is unclear. (Current Controlled Trials number, ISRCTN85753869 [controlled-trials.com]).
-
Letter Case Reports
Atrophic glossitis leading to the diagnosis of celiac disease.